Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista Española de Enfermedades Digestivas
versión impresa ISSN 1130-0108
Resumen
FORTEA ORMAECHEA, José Ignacio et al. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglubulinemia. Rev. esp. enferm. dig. [online]. 2013, vol.105, n.8, pp.490-493. ISSN 1130-0108. https://dx.doi.org/10.4321/S1130-01082013000800009.
Mixed cryoglobulinemia (MC) is a small-vessel systemic vasculitis characterized by the presence of cryoglobulins, immunoglobulin complexes that precipitate at low temperatures (< 37 oC) inducing the inflammatory process. The most frequent etiology is hepatitis C infection (HCV) (1). Rituximab (RTX), an anti-CD20 monoclonal antibody, has recently emerged as the treatment of choice for severe MC (2). We present a case of severe hepatitis C virus-induced MC that was controlled and maintained in remission with RTX for 26 months, a remarkable prolonged period of time.
Palabras clave : Cryoglobulinemia; Rituximab; Hepatitis C infection.